3-methoxytyramine has been researched along with Psychoses, Drug in 3 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yui, K | 3 |
Goto, K | 3 |
Ikemoto, S | 3 |
Ishiguro, T | 2 |
Kamata, Y | 1 |
Nishijima, K | 1 |
Yoshino, T | 1 |
1 trial available for 3-methoxytyramine and Psychoses, Drug
Article | Year |
---|---|
Spontaneous recurrence of methampetamine psychosis: increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic change.
Topics: Adaptation, Psychological; Adult; Analysis of Variance; Dopamine; Female; Humans; Methamphetamine; N | 1999 |
2 other studies available for 3-methoxytyramine and Psychoses, Drug
Article | Year |
---|---|
The role of noradrenergic and dopaminergic hyperactivity in the development of spontaneous recurrence of methamphetamine psychosis and susceptibility to episode recurrence.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Disease Susceptibility; Dopamine; Female; Huma | 2004 |
Susceptibility to subsequent episodes of spontaneous recurrence of methamphetamine psychosis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Arousal; Dopamine; Female; Humans; Life Change Events; Metham | 2001 |